YD Bio (NASDAQ:YDES) Trading 12.5% Higher – What’s Next?

YD Bio Limited (NASDAQ:YDES)’s share price shot up 12.5% on Tuesday . The company traded as high as $7.45 and last traded at $7.3010. 4,279 shares changed hands during trading, a decline of 88% from the average session volume of 36,567 shares. The stock had previously closed at $6.49.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on YDES. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen raised YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, YD Bio presently has a consensus rating of “Sell”.

YD Bio Stock Performance

The firm has a 50 day simple moving average of $9.59.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC grew its holdings in YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent filing with the SEC.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.